Below are five legal actions involving members of the drug supply chain, including pharmaceutical manufacturers and distributors, reported by Becker's Hospital Review in the last week:
- Oklahoma sues McKesson, Cardinal, AmerisourceBergen over the opioid crisis
Oklahoma Attorney General Mike Hunter filed a lawsuit against Cardinal Health, McKesson and AmerisourceBergen, three of the country's largest drug distributors, alleging they helped fuel the opioid crisis by funnelling "unreasonable" amounts of opioids into the state. - Roche pulled a $1.5B fast one on US, whistleblower physician alleges
Roche allegedly misled the U.S. government about the effectiveness of its drug, Tamiflu, at combating a flu pandemic, causing the government to unnecessarily spend $1.5 billion to stockpile the drug. - Endo settles Oklahoma opioid case for $8.8M
Endo Pharmaceuticals agreed to pay $8.8 million to Oklahoma to settle claims its marketing played a role in fueling the opioid crisis. - J&J agrees to $6.3M settlement linked to marketing of Infants' Tylenol
Johnson & Johnson has agreed to pay up to $6.3 million to customers who bought Infants' Tylenol since 2014 to settle a lawsuit claiming deceptive marketing practices. - Bristol-Myers, Sanofi sue Hawaii, accused of violating their free speech
Bristol-Myers Squibb and Sanofi, two of the world's largest drugmakers, filed a lawsuit against Hawaii Attorney General Clare Connors, claiming she violated their First Amendment rights.